Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

GSK

GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHO
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHOSwarajya StaffOct 8, 2021 10:33 AM +05:30 IST
A Major Breakthrough: WHO Approves World's First Vaccine Against Malaria
A Major Breakthrough: WHO Approves World's First Vaccine Against Malaria Bhaswati Guha Majumder Oct 7, 2021 01:06 PM +05:30 IST
GSK Back In Covid-19 Vaccination Race, Vaccine Candidate Jointly Developed By GSK-Sanofi Reports Success In Phase 2 Trial
GSK Back In Covid-19 Vaccination Race, Vaccine Candidate Jointly Developed By GSK-Sanofi Reports Success In Phase 2 TrialSwarajya StaffMay 17, 2021 12:49 PM +05:30 IST
UK’s Chief Scientific Adviser Patrick Vallance Faces Questions About Conflict Of Interest For Holding Shares in Pharma Giant GSK
UK’s Chief Scientific Adviser Patrick Vallance Faces Questions About Conflict Of Interest For Holding Shares in Pharma Giant GSKSwarajya StaffSep 25, 2020 07:22 PM +05:30 IST
Why India Should Not Bring A Vaccine Developed By Private Sector Under ‘Compulsory Licence’; History Suggests It Might
Why India Should Not Bring A Vaccine Developed By Private Sector Under ‘Compulsory Licence’; History Suggests It MightSatish ViswanathanSep 15, 2020 01:04 PM +05:30 IST
Horlicks Finds A New Home: Hindustan Unilever Emerges Favourite To Buy GSK’s Healthcare Unit
Horlicks Finds A New Home: Hindustan Unilever Emerges Favourite To Buy GSK’s Healthcare UnitSwarajya StaffDec 3, 2018 05:23 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype